RT Journal Article SR Electronic T1 First detection of Powassan Virus lineage I in field-collected Dermacentor variabilis from New York, USA JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2022.03.01.22271704 DO 10.1101/2022.03.01.22271704 A1 Charles Hart A1 Erin Hassett A1 Chantal B.F. Vogels A1 Daniel Shapley A1 Nathan D. Grubaugh A1 Saravanan Thangamani YR 2022 UL http://medrxiv.org/content/early/2022/03/02/2022.03.01.22271704.abstract AB Powassan virus (POWV) is a tick-borne flavivirus that can cause lethal or debilitating neurological illness. It is canonically transmitted by Ixodes genus ticks but may interact with sympatric Dermacentor species. Here, we report the first detection of POWV lineage I from a pool of field-collected D. variabilis in New York state.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study described in this manuscript was funded by Departmental Start-up funds, Upstate Foundation (Fund ID: 23709) and SUNY Empire Innovation Professorship funds to ST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript.